Business Context and Reporting Period
Company: LifeMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 10, 2025
Reporting Period: The filing announces financial results for the three months and the full year ended December 31, 2024, along with earnings guidance for 2025.
Key Financial Metrics
The provided text serves as a cover report referencing a press release (Exhibit 99.1) for detailed data. The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific comparative data or descriptions of material changes versus prior periods. It only indicates that such results were announced in a separate press release.
Guidance, Outlook, and Risks
Guidance: Management has issued earnings guidance for the 2025 fiscal year, though specific targets are not detailed in this text.
Legal Disclaimer: The information in Item 2.02 and the attached press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 10, 2025) for specific revenue, net income, and cash flow figures for Q4 and FY 2024.
- Verify the specific numerical targets included in the 2025 earnings guidance.
- Confirm the status of the Series A Cumulative Perpetual Preferred Stock (LFMDP) and Common Stock (LFMD) trading on The Nasdaq Global Market.
- Check for any unusual items or contingencies detailed in the full press release that are not summarized in this 8-K.